- Trials with a EudraCT protocol (149)
- Paediatric studies in scope of Art45 of the Paediatric Regulation (1)
149 result(s) found for: Hip fracture.
Displaying page 1 of 8.
EudraCT Number: 2015-000654-38 | Sponsor Protocol Number: AHUS2015-000654-38 | Start Date*: 2015-10-19 | |||||||||||
Sponsor Name:Akershus University Hospital, Norway | |||||||||||||
Full Title: Secondary prophylaxis after hip fracture. An evaluation og two organisational models based on choise of treatment: a comparison of efficacy and applicability of hospital based treatment with zoled... | |||||||||||||
Medical condition: Hip fracture | |||||||||||||
|
|||||||||||||
Population Age: Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: NO (Prematurely Ended) | |||||||||||||
Trial results: View results |
EudraCT Number: 2022-003163-21 | Sponsor Protocol Number: COTHUGMTRA22 | Start Date*: 2023-07-13 | |||||||||||
Sponsor Name:Coral Sánchez Pérez | |||||||||||||
Full Title: PHASE III, SINGLE-CENTER, DOUBLE-BLIND, RANDOMIZED, PLACEBO-CONTROLLED, LOW-INTERVENTION CLINICAL TRIAL IN TWO PARALLEL GROUPS, TO EVALUATE EFFICACY AND SAFETY IN ELDERLY PATIENTS WITH PERTROCHANTE... | |||||||||||||
Medical condition: pertrochanteric hip fracture | |||||||||||||
|
|||||||||||||
Population Age: Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: ES (Ongoing) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2017-001543-13 | Sponsor Protocol Number: HIP-SAP | Start Date*: 2018-03-28 | ||||||||||||||||||||||||||
Sponsor Name:Morten Tange Kristensen/Hvidovre Hospital | ||||||||||||||||||||||||||||
Full Title: Preliminary effect and safety of physiotherapy with strength training and protein-dense nutritional supplement in combination with anabolic steroids in cross-continuum rehabilitation of patients wi... | ||||||||||||||||||||||||||||
Medical condition: Area of investigation is recovery of muscle strength and function following hip fracture surgery. | ||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||
Population Age: Elderly | Gender: Male, Female | |||||||||||||||||||||||||||
Trial protocol: DK (Prematurely Ended) | ||||||||||||||||||||||||||||
Trial results: View results |
EudraCT Number: 2011-003142-41 | Sponsor Protocol Number: 20110142 | Start Date*: 2012-03-28 | |||||||||||
Sponsor Name:AMGEN INC. | |||||||||||||
Full Title: A Multicenter, International, Randomized, Double-blind, Alendronate-controlled Study to Determine the Efficacy and Safety of AMG 785 in the Treatment of Postmenopausal Women With Osteoporosis | |||||||||||||
Medical condition: Postmenopausal osteoporosis | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Female | ||||||||||||
Trial protocol: IT (Completed) LT (Completed) FI (Completed) PL (Completed) BE (Completed) CZ (Completed) ES (Completed) EE (Completed) GR (Completed) DE (Completed) GB (Completed) SE (Completed) AT (Completed) DK (Completed) LV (Completed) NO (Completed) NL (Completed) HU (Completed) IE (Completed) SK (Completed) BG (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2009-015939-33 | Sponsor Protocol Number: 20080394 | Start Date*: 2010-03-23 |
Sponsor Name:Amgen Inc | ||
Full Title: A Multi-center, Randomized, Double-blind, Placebo-controlled Study to Determine the Efficacy, Safety, and Tolerability of AMG 785 in Adults with Fresh Unilateral Intertrochanteric Fracture of the P... | ||
Medical condition: Acceleration of fracture healing | ||
Disease: | ||
Population Age: | Gender: Male, Female | |
Trial protocol: FR (Completed) GB (Completed) DE (Completed) SE (Completed) PL (Completed) DK (Completed) NL (Completed) LV (Completed) GR (Completed) IT (Completed) HU (Completed) BE (Completed) FI (Completed) LT (Completed) EE (Completed) BG (Completed) SI (Completed) | ||
Trial results: View results |
EudraCT Number: 2006-001832-34 | Sponsor Protocol Number: 3100N7-211-WW | Start Date*: 2007-01-11 | |||||||||||
Sponsor Name:Wyeth Pharmaceuticals Inc. | |||||||||||||
Full Title: A Phase 2, Multicenter, Single-Blind, Randomized, Stratified, Standard-of-Care Controlled, Feasibility and Safety Study of rhBMP-2/CPM as an Adjuvant Therapy for Fractures of the Proximal Femur | |||||||||||||
Medical condition: Closed fracture of the proximal femur | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: GB (Completed) FI (Completed) HU (Completed) FR (Completed) SE (Completed) DE (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2009-017153-35 | Sponsor Protocol Number: ALMED-08-C2-020 | Start Date*: 2010-04-06 | |||||||||||
Sponsor Name:AIR LIQUIDE SANTE INTERNATIONAL | |||||||||||||
Full Title: An international, multi-center, randomized, controlled trial evaluating the effect of xenon on post-operative delirium in elderly patients undergoing hip fracture surgery. | |||||||||||||
Medical condition: Post-operative delirium after hip fracture surgery under general anaesthesia | |||||||||||||
|
|||||||||||||
Population Age: Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: FR (Completed) DE (Completed) GB (Completed) ES (Completed) IT (Completed) BE (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2011-001456-11 | Sponsor Protocol Number: 20070337 | Start Date*: 2012-04-17 | |||||||||||
Sponsor Name:Amgen Inc | |||||||||||||
Full Title: A Multicenter, International, Randomized, Double-blind, Placebo controlled, Parallel-group Study to Assess the Efficacy and Safety of Romosozumab Treatment in Postmenopausal Women With Osteoporosis | |||||||||||||
Medical condition: Postmenopausal Osteoporosis | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Female | ||||||||||||
Trial protocol: HU (Completed) BE (Completed) DK (Completed) PL (Completed) DE (Completed) GB (Completed) EE (Completed) CZ (Completed) ES (Completed) LV (Completed) LT (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2019-004766-17 | Sponsor Protocol Number: zoledronate-fract-65-85yr | Start Date*: 2021-06-30 |
Sponsor Name:Region Uppsala | ||
Full Title: The Fragility Fracture Trial (FFT): A randomized, double-blind, placebo-controlled trial to investigate whether zoledronic acid prevents new fractures in older adults with a recent non-hip, non-ver... | ||
Medical condition: Non-hip, non-vertebral fragility fracture | ||
Disease: | ||
Population Age: Elderly | Gender: Male, Female | |
Trial protocol: SE (Completed) | ||
Trial results: (No results available) |
EudraCT Number: 2020-000638-17 | Sponsor Protocol Number: 44107 | Start Date*: 2021-03-30 |
Sponsor Name:Oslo University Hospital | ||
Full Title: ZOLEDRONATE EARLY TO HIP FRACTURE PATIENTS – SAFE AND EFFECTIVE? A DOUBLE-BLINDED RANDOMIZED CONTROLLED TREATMENT STRATEGY TRIAL ON ZOLEDRONATE IN HIP FRACTURE PATIENTS THE ZEBRA TRIAL | ||
Medical condition: Osteoporosis | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: NO (Trial now transitioned) | ||
Trial results: (No results available) |
EudraCT Number: 2020-004697-21 | Sponsor Protocol Number: PENG-CAD | Start Date*: 2020-12-11 | |||||||||||
Sponsor Name:Instituto de Investigación Biomédica de Salamanca | |||||||||||||
Full Title: RANDOMIZED AND CONTROLLED PHASE IV CLINICAL TRIAL ON THE ANALGESIC EFFECTIVENESS OF THE COMBINED BLOCKADE (PENG -PERICAPSULAR NERVE GROUP- AND THE FEMORAL LATERAL CUTANEOUS NERVE) IN THE HIP FRACTU... | |||||||||||||
Medical condition: Most appropriate anesthetic technique for surgery of hip fracture in the elderly | |||||||||||||
|
|||||||||||||
Population Age: Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: ES (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2016-002354-20 | Sponsor Protocol Number: VIK_001 | Start Date*: 2016-09-14 | |||||||||||
Sponsor Name:DOTT.SSA CARMELINDA RUGGIERO,ISTITUTO DI GERIATRIA E GERONTOLOGIA, UNIVERSITà DEGLI STUDI DI PERUGIA | |||||||||||||
Full Title: EFFECTIVNESS OF WARFARIN REVERSAL USING INTRAVENOUS VITAMIN K AMONG HIP FRACTURE OLDER PERSONS: A RANDOMIZED CLINICAL TRIAL | |||||||||||||
Medical condition: Hip fractured subjects on warfarin therapy | |||||||||||||
|
|||||||||||||
Population Age: Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: IT (Prematurely Ended) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2010-023871-25 | Sponsor Protocol Number: 2010-023871-25 | Start Date*: 2011-04-20 | |||||||||||||||||||||
Sponsor Name:Nottingham University Hospitals NHS Trust | |||||||||||||||||||||||
Full Title: The FINOF(Femoral Nerve-Block Intervention in Neck Of Femur Fracture) Study | |||||||||||||||||||||||
Medical condition: Pain and mobility following hip fracture in the elderly | |||||||||||||||||||||||
|
|||||||||||||||||||||||
Population Age: Elderly | Gender: Male, Female | ||||||||||||||||||||||
Trial protocol: GB (Completed) | |||||||||||||||||||||||
Trial results: View results |
EudraCT Number: 2020-002143-27 | Sponsor Protocol Number: 73950 | Start Date*: 2021-02-09 | |||||||||||
Sponsor Name:Maasstad Ziekenhuis | |||||||||||||
Full Title: Spinal morphine in patients with hip fractures to reduce delirium | |||||||||||||
Medical condition: Proximal femur fracture | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: NL (Completed) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2009-015865-30 | Sponsor Protocol Number: PAHFRAC-01 | Start Date*: 2010-06-24 | |||||||||||
Sponsor Name:Máximo Bernabeu Wittel | |||||||||||||
Full Title: ENSAYO CLINICO RANDOMIZADO DOBLE CIEGO DE HIERRO CARBOXIMALTOSA INTRAVENOSO CON O SIN ERITOPOYETINA PARA LA PREVENCIÓN DE TRANSFUSIONES DE CONCENTRADOS DE HEMATÍES EN EL PERIOPERATORIO DE FRACTURA ... | |||||||||||||
Medical condition: Pacientes adultos ingresados en el Hospital por fractura de cadera osteoporótica. Adult patients admitted in Hospital for osteoporotic hip fracture | |||||||||||||
|
|||||||||||||
Population Age: Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: ES (Completed) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2010-022816-38 | Sponsor Protocol Number: 2010-09-20 | Start Date*: 2010-12-22 | ||||||||||||||||
Sponsor Name:Department of Anesthesiology & Intensive Care | ||||||||||||||||||
Full Title: Preoperative Optimization of the High-Risk Patient undergoing Hip Fracture Surgery | ||||||||||||||||||
Medical condition: Patients with elevated NT-proBNP as a sign of left ventricular dysfunction undergoing hipfracturesurgery. | ||||||||||||||||||
|
||||||||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | |||||||||||||||||
Trial protocol: SE (Completed) | ||||||||||||||||||
Trial results: (No results available) |
EudraCT Number: 2018-000528-32 | Sponsor Protocol Number: TRaffiq | Start Date*: 2018-07-12 | |||||||||||
Sponsor Name:Consorci Mar Parc de Salut de Barcelona (Parc de Salut Mar) | |||||||||||||
Full Title: Tranexamic acid use to reduce de blood transfusion in femur fracture patients. Clinical randomized trial with placebo control | |||||||||||||
Medical condition: Bleeding in patients suffering femur neck fracture | |||||||||||||
|
|||||||||||||
Population Age: Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: ES (Ongoing) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2004-002746-35 | Sponsor Protocol Number: D4003C00030 | Start Date*: 2005-07-13 |
Sponsor Name:AstraZeneca AB | ||
Full Title: The "EXTEND" study: A randomized, double-blind, parallel-group, phase IIIb, multi-centre study evaluating extended prophylactic treatment with melagatran/ximelagatran versus enoxaparin for the prev... | ||
Medical condition: Prophylactic treatment for the prevention of venous thromboembolic events in patients undergoing elective hip replacement or hip fracture surgery. | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: FI (Completed) SE (Completed) HU (Completed) AT (Completed) DK (Completed) DE (Completed) PT (Prematurely Ended) ES (Completed) | ||
Trial results: View results |
EudraCT Number: 2014-001702-18 | Sponsor Protocol Number: protocol1tdn | Start Date*: 2014-08-28 | |||||||||||
Sponsor Name:Thomas Fichtner Bendtsen | |||||||||||||
Full Title: Analgesic duration of a preoperative single-shot femoral nerve block with Bupivacaine and adjuvant Dexamethasone in patients with hip fracture | |||||||||||||
Medical condition: Pain in patients with hip fracture | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: DK (Prematurely Ended) | |||||||||||||
Trial results: View results |
EudraCT Number: 2013-003439-31 | Sponsor Protocol Number: CBYM338D2201 | Start Date*: 2014-06-17 | ||||||||||||||||
Sponsor Name:Novartis Pharma Services AG | ||||||||||||||||||
Full Title: A 24-week Double-blind Treatment and 24-week Follow-up, Randomized, Multicenter, Placebo-controlled, Phase IIa/IIb Study to Evaluate Safety and Efficacy of i.v. Bimagrumab on Total Lean Body Mass a... | ||||||||||||||||||
Medical condition: Patients with muscle wasting (atrophy) after hip fracture surgery and subsequent postsurgical rehabilitation | ||||||||||||||||||
|
||||||||||||||||||
Population Age: Elderly | Gender: Male, Female | |||||||||||||||||
Trial protocol: BE (Completed) GB (Completed) DE (Completed) HU (Completed) CZ (Completed) AT (Completed) | ||||||||||||||||||
Trial results: View results |
Subscribe to this Search
To subscribe to the RSS feed for this search click here
.
This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
To subscribe to the RSS feed for this search click here

Download Options: | |
---|---|
Number of Trials to download: | |
Download Content: | |
Download Format: | |
Note, where multi-state trials are shown in search results, selecting "Full Trial details" will download full information for each of the member states/countries involved in the trial. |
• EEA CTAs: Date study was authorised to proceed
• Outside EU/EEA: Date study was submitted in EudraCT
• Outside EU/EEA: Date study was submitted in EudraCT
